The levels of polyQ-expanded huntingtin (HTT) protein detected by an anti-polyQ tract antibody (clone 1C2) markedly decreased following CWG-cPIP treatment in HD patient–derived fibroblasts compared with their levels in vehicle-treated fibroblasts. Here, HTT is linked to Huntington disease.